hydroxyindoleacetic acid has been researched along with MPTP Neurotoxicity Syndrome in 13 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Excerpt | Relevance | Reference |
---|---|---|
"Trichostatin A (TSA) was further used to study the effects of histone deacetylase inhibition on NRSF-mediated repression." | 1.42 | NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson's disease. ( Cai, L; Fei, J; Huang, D; Huang, F; Huang, L; Huang, Y; Liu, J; Ma, Y; Suo, H; Tong, J; Wang, P; Wang, Z; Xu, J; Yu, M, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (53.85) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 5 (38.46) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jones, BC | 1 |
Miller, DB | 1 |
O'Callaghan, JP | 1 |
Lu, L | 1 |
Unger, EL | 1 |
Alam, G | 1 |
Williams, RW | 1 |
Saitoh, K | 1 |
Abe, K | 1 |
Chiba, T | 1 |
Katagiri, N | 1 |
Saitoh, T | 1 |
Horiguchi, Y | 1 |
Nojima, H | 1 |
Taguchi, K | 1 |
Suo, H | 1 |
Wang, P | 1 |
Tong, J | 1 |
Cai, L | 1 |
Liu, J | 1 |
Huang, D | 1 |
Huang, L | 1 |
Wang, Z | 1 |
Huang, Y | 1 |
Xu, J | 1 |
Ma, Y | 2 |
Yu, M | 1 |
Fei, J | 1 |
Huang, F | 1 |
Maiti, P | 1 |
Gregg, LC | 1 |
McDonald, MP | 1 |
Li, XM | 1 |
Ma, HB | 1 |
Ma, ZQ | 1 |
Li, LF | 1 |
Xu, CL | 1 |
Qu, R | 1 |
Ma, SP | 1 |
Li, H | 1 |
He, Z | 1 |
Su, T | 1 |
Lu, S | 1 |
Dai, C | 1 |
Sun, M | 1 |
Pérez-Otaño, I | 1 |
Luquin, MR | 1 |
Oset, C | 1 |
Herrero, MT | 1 |
Kupsch, A | 1 |
Oertel, W | 1 |
Obeso, JA | 1 |
Del Río, J | 1 |
Tanila, H | 1 |
Björklund, M | 1 |
Riekkinen, P | 1 |
Cheng, FC | 1 |
Ni, DR | 1 |
Wu, MC | 1 |
Kuo, JS | 1 |
Chia, LG | 1 |
Donovan, DM | 1 |
Miner, LL | 1 |
Perry, MP | 1 |
Revay, RS | 1 |
Sharpe, LG | 1 |
Przedborski, S | 1 |
Kostic, V | 1 |
Philpot, RM | 1 |
Kirstein, CL | 1 |
Rothman, RB | 1 |
Schindler, CW | 1 |
Uhl, GR | 1 |
Bankiewicz, KS | 1 |
Plunkett, RJ | 1 |
Mefford, I | 1 |
Kopin, IJ | 1 |
Oldfield, EH | 1 |
Russ, H | 1 |
Mihatsch, W | 1 |
Gerlach, M | 1 |
Riederer, P | 1 |
Przuntek, H | 1 |
Bonuccelli, U | 1 |
Garant, D | 1 |
Fariello, R | 1 |
13 other studies available for hydroxyindoleacetic acid and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
Systems analysis of genetic variation in MPTP neurotoxicity in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biomarkers; Brain; Disease Models, Animal; Dopamine; Gene E | 2013 |
Properties of 3-methyl-TIQ and 3-methyl-N-propargyl-TIQ for preventing MPTP-induced parkinsonism-like symptoms in mice.
Topics: Animals; Antiparkinson Agents; Basal Ganglia; Behavior, Animal; Disease Models, Animal; Dopamine; Do | 2013 |
NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Cell Line, Tumor; Dopamine; Drug Evaluation, Preclin | 2015 |
MPTP-induced executive dysfunction is associated with altered prefrontal serotonergic function.
Topics: Animals; Attention; Corpus Striatum; Disease Models, Animal; Dopamine; Executive Function; Hydroxyin | 2016 |
Ameliorative and neuroprotective effect in MPTP model of Parkinson's disease by Zhen-Wu-Tang (ZWT), a traditional Chinese medicine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Chromatography, High Pressure Liquid; Cor | 2010 |
Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Cell Count; Dopamine; Hydroxyindoleacetic Acid; Injections, Intraventricu | 2003 |
Neurotoxicity induced by prenatal exposure to MPTP on the monoaminergic and peptidergic systems of the marmoset brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Callithrix; Dopamine; Enkephalin, Methionine; Female | 1995 |
Cognitive changes in mice following moderate MPTP exposure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Agonists; Animals; Cerebral Cortex; Cognition; Corp | 1998 |
Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL/6 mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Brain Chemistry; Disease Models, Animal; | 1998 |
Cocaine reward and MPTP toxicity: alteration by regional variant dopamine transporter overexpression.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Ani | 1999 |
Behavioral recovery from MPTP-induced parkinsonism in monkeys after intracerebral tissue implants is not related to CSF concentrations of dopamine metabolites.
Topics: Adrenal Medulla; Amnion; Animals; Brain Tissue Transplantation; Caudate Nucleus; Disease Models, Ani | 1990 |
Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amin | 1991 |
The acute convulsant effect of MPTP is dependent on intracerebral MPP+.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemist | 1991 |